198 related articles for article (PubMed ID: 29092734)
1. Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis - A retrospective analysis
.
Zhao Q; Shan W; Liu L; Fu X; Liu P; Hu Y
Int J Clin Pharmacol Ther; 2017 Dec; 55(12):893-900. PubMed ID: 29092734
[TBL] [Abstract][Full Text] [Related]
2. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
[TBL] [Abstract][Full Text] [Related]
4. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
Lei YS; Li H; Lei JY; Li SX; Li DF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
[TBL] [Abstract][Full Text] [Related]
6. Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
Huang P; Yi XY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9710-9720. PubMed ID: 37916334
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
[TBL] [Abstract][Full Text] [Related]
8. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
Al-Khaled M; Matthis C; Eggers J
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous thrombolysis on stroke associated with atrial fibrillation.
Padjen V; Jovanovic D; Berisavac I; Ercegovac M; Stefanovic Budimkic M; Stanarcevic P; Beslac Bumbasirevic L
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2199-2205. PubMed ID: 25018112
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction.
Wang R; Zeng J; Wang F; Zhuang X; Chen X; Miao J
QJM; 2019 May; 112(5):323-326. PubMed ID: 30566606
[TBL] [Abstract][Full Text] [Related]
13. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
[TBL] [Abstract][Full Text] [Related]
14. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
15. Select hyperacute complications of ischemic stroke: cerebral edema, hemorrhagic transformation, and orolingual angioedema secondary to intravenous Alteplase.
Bar B; Biller J
Expert Rev Neurother; 2018 Oct; 18(10):749-759. PubMed ID: 30215283
[TBL] [Abstract][Full Text] [Related]
16. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Prognosis in Ischemic Stroke Patients Treated with Intravenous Thrombolytic Therapy.
Stefanovic Budimkic M; Pekmezovic T; Beslac-Bumbasirevic L; Ercegovac M; Berisavac I; Stanarcevic P; Padjen V; Jovanović DR
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):196-203. PubMed ID: 28341074
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
[TBL] [Abstract][Full Text] [Related]
20. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki.
Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M
Stroke; 2003 Jun; 34(6):1443-9. PubMed ID: 12738891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
